Adherence During Antiviral Treatment Regimens for Chronic Hepatitis C A Qualitative Study of Patient-reported Facilitators and Barriers

被引:25
作者
Evon, Donna M. [1 ]
Golin, Carol E. [2 ,3 ]
Bonner, Jason E. [1 ]
Grodensky, Catherine [2 ]
Velloza, Jennifer [2 ]
机构
[1] Univ N Carolina, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Gillings Sch Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Div Gen Med & Clin Epidemiol, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
interferon; compliance; liver; dose; psychological; BEHAVIORAL SKILLS MODEL; ANTIRETROVIRAL THERAPY; MEDICATION; INFORMATION; EXPERIENCES; TELAPREVIR; MOTIVATION; MANAGEMENT;
D O I
10.1097/MCG.0000000000000151
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Goals: To understand patients' perceptions of factors which facilitate and hinder adherence to inform adherence-enhancing interventions. Background: Adherence to antiviral therapy for hepatitis C viral infection is critical to achieving a sustained virological response. However, persistence with and adherence to antiviral regimens can pose challenges for patients that interfere with sustained virological response. Study: A qualitative analysis of 21 semistructured patient interviews using open-ended questions and specific follow-up probes was conducted. Interviews were audio-recorded, transcribed, and content- analyzed iteratively to determine frequent and salient themes. Results: Three broad themes emerged: (1) missing doses and dose-timing errors; (2) facilitators of adherence; and (3) barriers to adherence. Open-ended questioning revealed few dose-timing deviations, but more specific probes uncovered several more occurrences of delays in dosing. Facilitators of adherence fell into 2 broad categories: (a) patient knowledge and motivation; and (b) practical behavioral strategies and routines. Facilitators were noted post hoc to be consistent with the Information-Motivation-Behavioral Skills Model of Adherence. Barriers to adherence involved changes in daily routine, being preoccupied with family or work responsibilities, and sleeping through dosing times. A few patients reported skipping doses due to side effects. Patients with previous hepatitis C virus treatment experience may have fewer dose-timing errors. Finally, a high level of anxiety among some patients was discovered regarding dosing errors. Emotional and informational support from clinical and research staff was key to assuaging patient fears. Conclusion: This qualitative study improves our understanding of patients' perspectives regarding adhering to hepatitis C treatment and can lead to the development of adherence-enhancing interventions.
引用
收藏
页码:E41 / E50
页数:10
相关论文
共 26 条
[1]   Enhanced adherence to HCV therapy with higher dose ribavirin formulation: final analyses from the ADHERE registry [J].
Alam, I. ;
Stainbrook, T. ;
Cecil, B. ;
Kistler, K. D. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (04) :535-542
[2]  
[Anonymous], EUR J HOSP PHARM SCI
[3]   Medication compliance and persistence: Terminology and definitions [J].
Cramer, Joyce A. ;
Roy, Anuja ;
Burrell, Anita ;
Fairchild, Carol J. ;
Fuldeore, Mahesh J. ;
Ollendorf, Daniel A. ;
Wong, Peter K. .
VALUE IN HEALTH, 2008, 11 (01) :44-47
[4]   Adherence to PEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistence [J].
Evon, D. M. ;
Esserman, D. A. ;
Bonner, J. E. ;
Rao, T. ;
Fried, M. W. ;
Golin, C. E. .
JOURNAL OF VIRAL HEPATITIS, 2013, 20 (08) :536-549
[5]   An information-motivation-behavioral skills model of adherence to antiretroviral therapy [J].
Fisher, Jeffrey D. ;
Fisher, William A. ;
Amico, K. Rivet ;
Harman, Jennifer J. .
HEALTH PSYCHOLOGY, 2006, 25 (04) :462-473
[6]   Patients' experiences related to anti-viral treatment for hepatitis C [J].
Fraenkel, Liana ;
McGraw, Sarah ;
Wongcharatrawee, Suchat ;
Garcia-Tsao, Guadalupe .
PATIENT EDUCATION AND COUNSELING, 2006, 62 (01) :148-155
[7]   Rapid Emergence of Telaprevir Resistant Hepatitis C Virus Strain from Wildtype Clone In Vivo [J].
Hiraga, Nobuttiko ;
Imamura, Michio ;
Abe, Hiromi ;
Hayes, C. Nelson ;
Kono, Tomohiko ;
Onishi, Mayu ;
Tsuge, Masataka ;
Takahashi, Shoichi ;
Ochi, Hidenori ;
Iwao, Eiji ;
Kamiya, Naohiro ;
Yamada, Ichimaro ;
Tateno, Chise ;
Yoshizato, Katsutoshi ;
Matsui, Hirotaka ;
Kanai, Akinori ;
Inaba, Toshiya ;
Tanaka, Shinji ;
Chayama, Kazuaki .
HEPATOLOGY, 2011, 54 (03) :781-788
[8]   Preferences for medical collaboration: patient-physician congruence and patient outcomes [J].
Jahng, KH ;
Martin, LR ;
Golin, CE ;
DiMatteo, MR .
PATIENT EDUCATION AND COUNSELING, 2005, 57 (03) :308-314
[9]   The Application of the Yerkes-Dodson Law in a Childhood Weight Management Program: Examining Weight Dissatisfaction [J].
Johnston, Craig A. ;
Moreno, Jennette Palcic ;
Regas, Kaleigh ;
Tyler, Chermaine ;
Foreyt, John P. .
JOURNAL OF PEDIATRIC PSYCHOLOGY, 2012, 37 (06) :674-679
[10]   Taking antiretroviral therapy for HIV infection - Learning from patients' stories [J].
Laws, MB ;
Wilson, IB ;
Bowser, DM ;
Kerr, SM .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2000, 15 (12) :848-858